1)九嶋亮治,松原亜季子,谷口浩和,他.低異型度分化型胃癌の病理学的特徴─腺腫との鑑別を含めて.胃と腸 45:1086-1096, 2010
2)Yao T, Utsunomiya T, Oya M, et al. Extremely well-differentiated adenocarcinoma of the stomach:Clinicopathological and immunohistochemical features. World J Gastroenterol 12:2510-2516, 2006
3)Niimi C, Goto H, Ohmiya N, et al. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma. Am J Clin Pathol 118:683-692, 2002
4)海崎泰治,細川治,宮永太門,他.低異型度分化型胃癌の自然史.胃と腸 45:1182-1191, 2010
5)Lee WA. Gastric extremely well differentiated adenocarcinoma of gastric phenotype:as a gastric counterpart of adenoma malignum of the uterine cervix. World J Surg Oncol 3:28-33, 2005
6)Nokubi M, Kawanowa K, Kawata H, et al. Extremely well-differentiated adenocarcinoma of the gastric cardia:A unique case with columnar cells and laminated stones. Pathol Int 54:854-860, 2004
7)渡辺英伸.胃癌・大腸癌の悪性度診断とは.病理と臨 23:932-943, 2005
8)渡辺英伸,加藤法導,渕上忠彦,他.微小胃癌からみた胃癌の発育経過.胃と腸 27:59-67, 1992
9)Saito A, Shimoda T, Nakanishi Y, et al. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 51:165-171, 2001
10)Liu G, Xiong D, Zeng J, et al. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer:a systematic review and meta-analysis. Onco Targets Ther 10:4321-4328, 2017
11)Luo G, Hu Y, Zhang Z, et al. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer:a meta-analysis. Oncotarget 8:50273-50283, 2017
12)西倉健,味岡洋一,渡邉玄,他.低異型度分化型胃癌の病理学的特徴─肉眼像を含めて.胃と腸 45:1061-1072, 2010
13)入口陽介,小田丈二,水谷勝,他.低異型度分化型胃癌のX線像の検討.胃と腸 45:1097-1113, 2010